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The identification of the structures recognized by syngeneic ytotoxic T lympho- 
cytes (CTL) 1 is complicated by the necessity for these cells to recognize, on the target 
cell surface, both antigen (Ag) and certain products of the major histocompatibility 
complex, rather than the Ag alone (1). To develop a general procedure for the 
identification of the Ag (such as those on virus infected or tumor ceils), we have 
investigated the ability of synthetic phospholipid vesicles (liposomes), containing 
purified Ag, to specifically elicit the development ofthe corresponding CTL. We show 
here that CTL primed in vivo can be stimulated in a secondary response by liposomes 
containing both a single purified protein of vesicular stomatitis virus (VSV), the G or 
glycoprotein, and solubilized membrane proteins from cells of the same H-2 haplotype 
as the CTL and the VSV-infected target cells. Responder cells from (H-2 d × H-2 ~) 
hybrid mice (d × b) and liposomes that contained G protein plus membrane proteins 
from cells of the parental H-2 haplotype, d or b, provided particularly striking evidence 
that CTL precursors were stimulated by intact liposomes, rather than by substances 
that were released from liposomes and subsequently adsorbed onto cells of the 
responder population. 
Materials and Methods 
Mice and Cultured Cells. H-2 haplotypes are in parentheses. BALB/cAnN (d) and H-2 
congenic BALB.B (b) mice were bred at the Center for Cancer Research, Massachusetts 
Institute of Technology. (BALB/cAnN × BALB.B) F1 hybrids were produced at Bowman 
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from the American Cancer Society (IM-161), and the North Carolina United Way and Forsythe Cancer 
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Present address: Department ofMedicine, Peter Bent Brigham Hospital, Boston, Massachusetts 02115. 
§ Alonzo H. Ross is a Damon Runyon-Walter Winchell Cancer Fund Fellow (DRG-144-FT). 
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1 Abbreviations u ed in this paper: Ag, antigen(s); CTL, cytotoxic T lymphocytes; DMPC, dimyristoylphos- 
phatidylcholine; G protein, purified glycoprotein of VSV; HLA, histocompatibility complex antigens; 
PBS, phosphate-buffered saline; PFU, plaque-forming unit(s); PMP, plasma membrane proteins; VSV, 
vesicular stomatitis virus. 
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Gray School of Medicine. The following cell lines were maintained in culture: P815 (d), a 
mastocytoma of DBA/2 origin, generously provided by M. Bevan, M.I.T.; EL-4 (b), a thymus 
lymphoma of C57BL/6 (B6) origin, kindly donated by H. Winn, Massachusetts General 
Hospital; MC57G (b), a macrophage-like c ll line of B6 origin, kindly provided by Barbara 
Knowles, Wistar Institute; 3T3 fibroblasts were derived from BALB/c (d), BALB.B (b), and 
BALB.K (k) mice (2). 
Viral and Cell Membrane Proteins. VSV and the virion glycoprotein (G protein) were produced 
and isolated as described (2, 3), In sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
the G protein migrated as a single band; its concentration was determined by the Lowry et al. 
method (4). 
Plasma membranes were prepared as described (5). Briefly, ca. 6 × 109 cells were disrupted 
by gentle homogenization i  10 mM Tris (pH 7.8), 10 mM NaCI, 1 mM MgCI2, and I mM 
phenymethyisulfonylfluoride. After low speed (400 g) centrifugation to remove nuclei and 
intact cells, crude membranes were obtained by centrifuging the supernate at 20,000 g for 0.5 
h. The resulting pellet was resuspended in 40% sucrose in 10 mM Tris (pH 7.4), overlaid with 
30% sucrose in 10 mM Tris (pH 7.4), and spun at 80,000 g for 18 h. The turbid interfacial 
band, containing plasma membrane (6), was removed and freed of sucrose by repeated 
centrifugations. The washed membranes, resuspended in PBS, were used immediately or frozen 
at -70 °. The membranes were stirred overnight at 22°C with 0.5% Na deoxycholate, 0.45 M 
KCI, 10 mM Tris, pH 7.9; then, after centrifugation at 180,000 g for 1 h, the protein content 
of the supernate (plasma membrane proteins or PMP) was determined by measuring optical 
density, assuming 1mg of protein/ml had an absorbance at 280 nm of 1.0. P815 and EL4 cells 
were used, respectively, assources of PMP of H-2 a and H-2 b type. 
Preparations of Phospholipid Vesicles. A modified procedure of Kagawa and Racker was used 
(7). Dimyristoylphosphatidylcholine (DMPC), purchased from Calbiochem-Behring Corp., 
American Hoechst Corp. (San Diego, Calif.), was used without further purification. Cholic 
acid, purchased from Sigma Chemical Co. (St. Louis, Mo.), was decolorized with activated 
charcoal and recrystallized twice from acetone. In a typical preparation, 0.6 mg DMPC, dried 
from chloroform under N2, was suspended in 0,6 ml of cholic acid (4 mg/ml, pH 7.5) with a 
vortex mixer and was then sonicated for 15 min. After adding 10-20 #g of G protein (in 0.1 ml) 
and/or 300-400 #g of solubilized plasma membrane proteins (in 3-4 ml) the mixture was 
incubated for 1 h and then dialyzed overnight (all at room temperature) against 4 liters of 10 
mM Tris, pH 7.5. To facilitate removal of deoxycholate, 20 ml (packed volume) of SM-2 Bio- 
Beads (Bio-Rad Laboratories, Richmond, Calif.) were added to the dialysis buffer. The 
liposomes that formed were packed by centrifugation (40,000 g), resuspended in 100 #1 PBS, 
and sterilized under UV light (4 h, 15 cm from a Westinghouse terilamp G 15T8, Westinghouse 
Electric Corp., Pittsburgh, Pa.) before being added to spleen cell cultures. Through the use of 
12~I-labeled G protein and lsXI-plasma membrane proteins (PMP), it was found that ~60% of 
the added G protein and ~30% of the added PMP were incorporated into the liposomes, 
whether G protein and PMP were incorporated into liposomes individually or together. The 
liposomes were shown by electron microscopy to range in diameter from 600 to 1,000 A (D. 
Loh, unpublished material, 11) and to be unilamellar (11). 
Immunization a d Generation of Effector Cells. Mice were injected (primed) intravenously with 
0.5 -1 .0  )< 10 7 plaque-forming units (PFU) of plaque-purified VSV (not inactivated) in PBS. 
5-10 wk later, 8 × 106 spleen cells, cleared of erythrocytes, were cultured in vitro with UV- 
inactivated VSV (3-6 × 107 PFU before inactivation) or with liposomes containing one of the 
following: (a) G protein (ca 1.5 #g) plus PMP (10 #g), or (b) G protein alone (1.5 p,g), or (c) 
PMP alone (10/~g), or (d) a mixture of (b) and (c). After 5 d, the cells were tested for ability to 
lyse 51Cr-labeted VSV-infected target cells (2). Target cells were prepared by infecting P815 or 
MC57G cells or various congenic BALB 3T3 flbroblasts with VSV at a multiplicity of 20-25; 
3.5 hrs later the cells were labeled with 51Cr (8). 5 × 104 target cells and various numbers of 
effector cells were incubated for 6 h in 12 × 75-mm round-bottom plastic tubes (Falcon 
Labware, Div. of Becton, Dickinson, & Co., Oxnard, Calif.) in a final vol of 400 p.l. Controls for 
the effector cells in each assay included spleen cells from both primed and umprimed mice, 
cultured for 5 d in the absence of Ag (VSV or G protein or PMP). 
Specific lysis resulting from the secondary stimulus was calculated as 100 (E-C/100-C) where 
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Elc. 1. H-2 restriction of the ]ytic activit 7 of anti-VSV CTLs elicited by phospholipld vesicles. 
Target cells were SlCr-labeled VSV-infected P815 (H-2 a) or MC57G (H-2~ cells. A. Secondary 
response by spleen cells from VSV-primed BALB/c (H-2 d) mice elicited in culture with vesicles 
containing VSV G protein and plasma membrane proteins from H-2 d cells (P815). B. Secondary 
response by spleen cells from VSV-primed BALB.B (H-2 b) mice elicited in culture with vesicles 
containing VSV G protein and plasma membrane proteins from H-2 b cells (EL-4). 
E is the percentage of 5aCr-released byprimed and boosted spleen cells and C is the percentage 
of 5~Cr-released by primed, but not boosted, spleen cells. Values for C were typically 15-20%; 
in control assays with nonprimed and nonboosted spleen cells, 10-20% of target cell 5~Cr was 
usually released. 
Media. The media used for cell culture and for cytotoxicity assays were RPMI-1640 
supplemented as described (2). 
Results and Discussion 
A previous tudy of target cells infected with temperature-sensitive mutants of VSV 
showed that anti-VSV CTL lyse only target cells that have both the correct H-2 
haplotype and G on the target cell surface (2). To determine whether purified G can 
elicit the formation of anti-VSV CTLs, we examined the response of spleen cells from 
VSV-primed mice to liposomes containing G. Spleen cells removed 6 d after a single 
intravenous injection of VSV have considerable CTL activity; however, 5-6 weeks 
later CTL activity is no longer detectable. To stimulate a secondary CTL response, 
spleen cells taken 6-8 w after one i.v. injection of VSV were incubated for 5 d with 
liposomes containing purified G protein, with or without cell membrane proteins; the 
spleen cells were then tested on VSV-infected target cells with various H-2 haplotypes. 
As is shown in Fig. 1, when primed spleen cells from BALB/c (H-2 d) mice were 
incubated with liposomes that contained both purified G and membrane proteins 
from H-2 a cells, they elicited CTLs that were VSV-specific and H-2 restricted: they 
lysed VSV-infected H-2 a cells (P815) but neither VSV-infected H-2 b cells (MC57G) 
(Fig. 1 A) nor uninfected P815 cells (not shown). Parallel results were obtained with 
primed spleen cells from congenie BALB.B (H-2 b) mice: the CTL they formed in 
response to liposomes having G and PMP from H-2 b cells lysed VSV-infected H-2 b 
cells (MC57G), not VSV-infected H-2 a cells (P815) (Fig. 1 B). 
The triggering of the secondary CTL response also required a match between the 
H-2 haplotype of the primed spleen cells and the cells whose membrane proteins were 
included, with G, in the liposomes. As is shown in Fig. 2, anti-VSV CTLs were elicited 
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Etc. 2. H-2 restriction in the generation ofanti-VSV CTLs by incubating spleen cells from VSV- 
primed BALB/c (H-2 d) and BALB.B (H-2 b) mice with phospholipid vesicles containing VSV G 
• d protein and plasma membrane proteins from uninfected P815 (H-2) cells or EL-4 (H-2 h) cells, 
designated G/PMP-H-2 d (O) and G/PMP-H-2 b (A), respectively. A The primed mice were BALB/ 
c and the target cells were 51Cr-labeled VSV-infected P815 cells (H-2d). B. The primed mice were 
BALB.B and the target cells were 51Cr-labeled VSV-infected MC57G cells (H-2b). 
in primed spleen cells from H-2 d mice (BALB/c) by liposomes with G + PMP from 
H-2 d cells, not by liposomes with G + PMP from H-2 b cells, and the reverse was 
observed with primed spleen cells from H-2 b mice (BALB.B). These results strongly 
imply that CTL precursors were stimulated by intact liposomes: if G protein was 
released and then elicited CTL, the H-2 haplotype of the cells whose membrane 
proteins were incorporated into liposomes would have been irrelevant. 
The effectiveness of intact liposomes was brought out especially forceably with 
primed spleen cells from VSV-infected (BALB/c X BALB.B)F1 hybrid mice, for 
simplicity called d X b. Anti-VSV CTLs could be elicited in these d X b spleen cells 
with G-bearing liposomes that contained membrane proteins from cells with either 
parental H-2 haplotype, H-2 b or H-2 a (Table I). There is considerable evidence that 
Ft hybrids form two sets of Ag-specific CTLs, one for Ag + H-2 of one parent and the 
other for Ag + H-2 of the other parent (9). In accord with this evidence, the d X b 
CTL elicited with liposomes that contained G + PMP from H-2 d cells lysed VSV- 
infected target cells with the H-2 d haplotype, not targets with the H-2 b haplotype, 
whereas the d X b CTL elicited with G + H-2 b membrane proteins lysed only VSV- 
infected targets with the H-2 b haplotype (Table I). Again, if d × b CTL were elicited 
by the G protein released from disintegrated liposomes it would be expected that the 
resulting anti-VSV CTLs would have lysed infected H-2 d and H-2 b targets, regardless 
of which liposomes elicited the killer cells. It has been proposed that T cells recognize 
not intact Ag molecules but processed Ag fragments on macrophages (e.g., reference 
10). The findings in Table I suggest, however, that Ag processing is not necessary, at 
least for the specific stimulation of secondary CTL responses• 
In contrast o the stimulator activity of liposomes with G + PMP (from cells of the 
correct H-2 haplotype), liposomes with G alone, or with the PMP alone, were 
ineffective. A mixture of the G-alone and the PMP-alone liposomes was also ineffective 
(Fig. 3). This means that for effective interaction with CTL  precursors the G and H- 
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TABLE 1 
Spleen CeUs from Primed (H-2 a × H-2 ~) Hybrid Mice Respond in Culture to Phospholipid Vesicles 
Containing G Glycoprotein and Plasma Membrane Proteins from Uninfected Cells of Parental H-2 
Haplotype 
Liposomes contain 
Percent specific lysis of VSV-infected target cells* 
3T3 Fibroblasts 
P815 MC57G BALB/c BALB.B BALB.K:I: 
(H-2 a) (H-2 b) (H-2 a) (H-2 b) (H-2 k) 
G alone 4.8 4.6 5.0 5.2 -2.4 
G + membrane proteins from H-2 a cells 46.7 3.5 18.8 5.1 0.3 
G + membrane proteins from H-2 b cells 5.0 43.9 2.7 24.0 0.2 
* Additional controls (A. H. Hale, unpublished material) were carried out by incubating spleen cells from 
VSV-primed (H-2 a × H-2 b) F1 mice with the following mixtures of liposomes, containing G protein and/ 
or plasma membrane proteins from H-2 a or H-2 b cells (designated as PMP-H-2 a or PMP-H-2 b, 
respectively): 
(No. 1) (G + PMP-H-2 b) liposomes mixed with (G + PMP-H-2 a) liposomes 
(No. 2) (G + PMP-H-2 b) liposomes mixed with (PMP-H-2 a) liposomes 
(No. 3) (G + PMP-H-2 a) liposnmes mixed with (PMP-H-2 b) liposomes. 
Percent specific lysis of VSV-infected H-2 a and H-2 b target cells (P815 and MC57G, respectively) were 
as follows (at E:T ratio 100:1): 
mixture no. 1--26.8, $7.3 
mixture no. 2--6.7, 41.8 
mixture no. 3--31.8, 10.2. 
In these controls the liposomes were prepared with egg lecithin-cholesterol (70:30, wt/wt) and the 
indicated proteins in 0.2% deoxycholate; vortex mixing was used to disperse the lipids and dialysis to 
remove the deoxycholate. 
When tested separately these targets were shown to be specifically lysed (38.4%) by primary response 
CTLs spleen cells taken from BALB.K mice 6 d after an intravenous injection of 2 × 107 PFU of VSV. 
2 molecules had to be in the same liposome, or closer together than  600-1,000 A, the 
d iameter  of the un i lamel la r  vesicles used in this study (11, and  also A. H. Ross and  H. 
G. Khorana ,  unpub l i shed  results). 
For compar ison with l iposomes, UV- inact ivated  VSV and  soluble G protein,  not 
incorporated into vesicles, were also tested on VSV-pr imed spleen cells. The  inacti-  
vated virus regular ly elicited as much CTL  activity as active l iposomes (data not 
shown). 2 In contrast,  G protein,  added at 5, 10, 50, and  100 #g/wel l ,  failed to elicit a 
s ignif icant response (data not  shown); however, in a few trials, where lysis elicited by 
l iposomes (with G and  PMP from cells with the correct H-2 haplotype) was relatively 
high (e.g., 60-70% specific lysis), some cytolytie act ivity was elicited by soluble G 
protein,  but  the response was low (ca. 10-15%) and  not reproducible.  
Two previous tudies showed that Ag-conta in ing  l iposomes can elicit CTL .  Puri f ied 
2 In many trials stimulation of the primed spleen cells by the inactivated virus also resulted in a low 
level of lysis of uninfected P815 cells, especially when the activity elicited againt VSV-infected P815 was 
high (e.g., 60% specific lysis). A definite explanation for the low-level, apparently nonspecific ytotoxic 
activity is not available (but see ref. 21 for one suggestion). 
 o
n
 D
ecem
ber 28, 2006 
w
w
w
.jem.org
D
ow
nloaded from
 
1072 PHOSPHOLIPID VESICLES ELICIT CYTOTOXIC T LYMPHOCYTES 
5O 
4O 
d 3O 
.~_ • 
,-~ 20 
o3 
I0 
2O 
G/PMP-H-2  d 
~G only 
PMP-H-2 d only 
only + PMP-H-2 d only 
A 
I I 
I00 60 
E:T  Rat io 
FxG. 3. Stimulation of CTL activity in spleen cells from VSV-primed BALB/c (H-2 d) mice by 
variously prepared liposomes: 0, vesicles with VSV G protein + membrane proteins from P815 (H- 
2 d) cells [G/PMP-H-2d]. A, vesicles with G protein only, or only with P815 membrane proteins, or 
a mixture of the two kinds of vesicles (G only and PMP only). 
histocompatibility leukocyte antigens (HLA) in liposomes were used by Englehard et 
al. (12) to stimulate the development of mouse CTL that specifically lysed human 
cells of the correct HLA type, and Finberg, et al. (13) used liposomes containing a
mixture of Sendai virus Ags (plus cell membrane proteins of the correct H-2 haplotype) 
to elicit H-2 restricted CTLs that lysed Sendai virus-infected target cells. However, 
Sendai virus proteins cause cells to fuse (14), and probably liposomes and cells to fuse, 
whereas VSV and purified G protein have no fusing activity (15). It is not clear, 
therefore, that Sendai-liposomes and the VSV-liposomes described here function in 
precisely the same manner. 
Even without being incorporated into lipid vesicles, some isolated proteins can 
apparently elicit H-2 restricted CTLs (16-20). It is probable that these proteins bind 
to cells of the responder population and that the bound protein, through proximity 
with the appropriate H-2 encoded surface molecules on the same cells, is effectively 
presented to CTL precursors. Alternatively, it has been suggested that the soluble 
proteins (bound or unbound) might stimulate T helpers to secrete mediators that 
nonspecifically trigger the differentiation of any CTL precursors in the responder 
population (21). In the present study, however, there was a striking difference between 
soluble G and the G that was incorporated (along with cell membrane proteins) into 
liposomes: whereas 1.5 #g of G in liposomes (with H-2 proteins) consistently elicited 
secondary CTL (Figs. 1-3), soluble G, in amounts up to 100 /~g was generally 
ineffective. 
The identity of the Ags (and antigenic determinants) that determine the specificity 
of CTL and other T cells has been difficult to establish. With the finding that purified 
protein in intact liposomes (along with the appropriate H-2 products) can specifically 
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elicit secondary CTL  it may be possible to define unambiguously not only the Ag 
molecules but the antigenic determinants hat are recognized by the T cells. 
Summary  
Synthetic phospholipid vesicles (liposomes) containing the purified glycoprotein 
((3) of vesicular stomatitis virus (VSV) and solubilized membrane proteins from cells 
of the appropriate H-2 haplotype licited H-2-restricted cytotoxic T lymphocytes 
(CTL) that lysed VSV-infected target cells. The CTL  were elicited by intact liposomes, 
not by released components. Thus, when spleen cells from VSV-primed H-2 d × H-2 h 
hybrid mice were stimulated with liposomes having G protein + membrane proteins 
from cells with one of the parental H-2 haplotypes, the resulting CTL  lysed only 
VSV-infected target cells with that parent's H-2 type. This result argues against he 
view that T cells in general recognize only processed antigenic fragments on macro- 
phages. Moreover, liposomes were only effective when G protein and cell membrane 
proteins were included in the same vesicles. This result suggests that for effective 
interaction with CTL  precursors the antigen (G protein) and products of the H-2 
complex must be closer to each other than 600-1,000 A, the diameter of the lipid 
vesicles used in this study. 
Received for publication 29 May 1979. 
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